Petros Pharmaceuticals (PTPI) Short Interest Ratio & Short Volume $0.07 -0.02 (-19.65%) Closing price 03/31/2025 04:00 PM EasternExtended Trading$0.07 0.00 (0.00%) As of 03/31/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Petros Pharmaceuticals Short Interest DataPetros Pharmaceuticals (PTPI) has a short interest of 745,300 shares, representing 7.50% of the float (the number of shares available for trading by the public). This marks a 113.06% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 9.03 million shares to cover all short positions.Current Short Interest745,300 sharesPrevious Short Interest349,800 sharesChange Vs. Previous Month+113.06%Dollar Volume Sold Short$62,903.32Short Interest Ratio0.1 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares11,319,000 sharesShort Percent of Float7.50%Today's Trading Volume12,332,212 sharesAverage Trading Volume9,031,276 sharesToday's Volume Vs. Average137% Short Selling Petros Pharmaceuticals? Sign up to receive the latest short interest report for Petros Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPTPI Short Interest Over TimePTPI Days to Cover Over TimePTPI Percentage of Float Shorted Over Time Remove Ads Petros Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2025745,300 shares $62,903.32 +113.1%7.5%0.1 $0.08 2/28/2025349,800 shares $34,210.44 -83.3%3.5%0.1 $0.10 2/15/20252,100,000 shares $615,300.00 +187.3%21.1%0.4 $0.29 1/31/2025731,000 shares $204,460.70 +15.7%N/A0.4 $0.28 1/15/2025631,800 shares $189,540.00 -2.2%6.9%0.3 $0.30 12/31/2024646,200 shares $254,538.18 +139.6%7.1%0.3 $0.39 12/15/2024269,700 shares $88,947.06 +48.9%3.0%0.2 $0.33 11/30/2024181,100 shares $49,693.84 -9.7%2.0%0.9 $0.27 11/15/2024200,600 shares $51,955.40 +0.7%2.2%1.1 $0.26 10/31/2024199,200 shares $73,704.00 -27.2%2.2%1.2 $0.37 Get the Latest News and Ratings for PTPI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Petros Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 10/15/2024273,600 shares $83,393.28 -7.2%3.1%1.4 $0.30 9/30/2024294,900 shares $105,279.30 +25.4%3.4%1.3 $0.36 9/15/2024235,100 shares $85,650.93 -20.6%2.7%0.8 $0.36 8/31/2024295,900 shares $98,445.93 +13.5%3.5%0.8 $0.33 8/15/2024260,700 shares $86,969.52 -40.0%3.1%0.6 $0.33 7/31/2024434,200 shares $176,285.20 +69.9%7.1%1 $0.41 7/15/2024255,500 shares $115,997.00 -28.5%4.2%0.6 $0.45 6/30/2024357,200 shares $163,419.00 -23.7%5.8%1 $0.46 6/15/2024468,300 shares $194,578.65 +202.3%7.7%1 $0.42 5/31/2024154,900 shares $95,139.58 +82.9%2.5%0.3 $0.61 5/15/202484,700 shares $43,671.32 -37.0%1.4%0.1 $0.52 4/30/2024134,500 shares $88,299.25 +92.7%3.3%0.2 $0.66 4/15/202469,800 shares $54,660.38 -52.3%1.7%0.1 $0.78 3/31/2024146,200 shares $216,376.00 +65.4%3.6%0.1 $1.48 3/15/202488,400 shares $134,368.00 -72.1%6.8%0.1 $1.52 2/29/2024317,200 shares $545,584.00 +12.3%24.2%0.3 $1.72 2/15/2024282,400 shares $434,896.00 +16.5%21.9%0.3 $1.54 1/31/2024242,400 shares $293,304.00 +2,208.6%18.8%0.4 $1.21 1/15/202410,500 shares $13,807.50 -74.8%0.8%0 $1.32 12/31/202341,700 shares $58,797.00 -66.5%3.1%0.2 $1.41 12/15/2023124,300 shares $172,777.00 +571.9%9.1%0.6 $1.39 11/30/202318,500 shares $29,600.00 -28.3%1.4%0.2 $1.60 11/15/202325,800 shares $34,314.00 -41.6%2.0%0.8 $1.33 10/31/202344,200 shares $63,206.00 -27.9%3.5%1.3 $1.43 10/15/202361,300 shares $98,073.87 +415.1%4.9%1.4 $1.60 9/30/202311,900 shares $20,585.81 +213.2%0.9%0 $1.73 9/15/20233,800 shares $6,878.00 -82.3%0.3%0 $1.81 8/31/202321,500 shares $54,825.00 -62.7%1.7%0.1 $2.55 8/15/202357,700 shares $184,640.00 -21.9%3.9%0.2 $3.20 7/31/202373,900 shares $296,339.00 -79.4%5.0%0.2 $4.01Crypto Genius: 12,000% in 12 months? [Here’s how] (Ad)We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.If I’m right about this (like I was before) a modest $900 investment… 7/15/2023359,100 shares $1.14 million +1,330.7%24.3%0.5 $3.19 6/30/202325,100 shares $50,953.00 -27.0%1.7%0 $2.03 6/15/202334,400 shares $89,784.00 -10.7%2.3%0 $2.61 5/31/202338,500 shares $89,705.00 -13.5%2.6%0 $2.33 5/15/202344,500 shares $186,900.00 -88.5%3.0%0 $4.20 4/30/2023385,300 shares $1.66 million +1,029.9%27.3%0.2 $4.30 4/15/202334,100 shares $156,519.00 -22.5%2.4%0 $4.59 3/31/202344,000 shares $61,380.00 +14.9%3.1%3.1 $1.40 3/15/202338,300 shares $56,684.00 +13.0%2.7%2.1 $1.48 2/28/202333,900 shares $71,190.00 -6.6%2.4%1.6 $2.10 2/15/202336,300 shares $92,202.00 +23.1%2.5%1.8 $2.54 1/31/202329,500 shares $76,700.00 -24.4%2.1%1.5 $2.60 1/15/202339,000 shares $118,950.00 +14.0%2.7%1.6 $3.05 12/30/202234,200 shares $79,686.00 +14.8%2.4%1.4 $2.33 12/15/202229,800 shares $63,176.00 +43.3%2.1%1.8 $2.12 11/30/202220,800 shares $8,550.88 -92.2%1.4%1.5 $0.41 11/15/2022265,700 shares $130,193.00 +78.6%N/A2.1 $0.49 10/31/2022148,800 shares $71,424.00 +9.3%N/A1 $0.48 10/15/2022136,200 shares $58,525.14 +77.3%N/A0.2 $0.43 9/30/202276,800 shares $39,168.00 -36.1%N/A0.1 $0.51 9/15/2022120,200 shares $78,682.92 -7.1%N/A0.1 $0.65 8/31/2022129,400 shares $84,821.70 +45.4%N/A0.1 $0.66 8/15/202289,000 shares $71,627.20 +420.5%N/A0.1 $0.80 7/31/202217,100 shares $13,573.98 -22.3%N/A0 $0.79 7/15/202222,000 shares $18,099.40 -56.2%N/A0.1 $0.82 6/30/202250,200 shares $42,157.96 +46.8%N/A0 $0.84 6/15/202234,200 shares $26,744.40 -81.0%N/A0 $0.78 5/31/2022179,500 shares $174,976.60 +89.2%N/A0.1 $0.97 5/15/202294,900 shares $91,113.49 -30.0%N/A0.1 $0.96 4/30/2022135,600 shares $153,228.00 -26.0%N/A0.1 $1.13 4/15/2022183,300 shares $221,793.00 -39.8%N/A0.1 $1.21 3/31/2022304,400 shares $474,864.00 +15.1%N/A0.4 $1.56 3/15/2022264,500 shares $285,660.00 -39.7%N/A0.1 $1.08 2/28/2022438,900 shares $605,682.00 -38.5%N/A0.1 $1.38 2/15/2022714,000 shares $1.14 million -15.3%N/A0.1 $1.59 1/31/2022842,700 shares $1.46 million -54.9%N/A0.1 $1.73 1/15/20221,870,000 shares $4.90 million -19.7%N/A0.1 $2.62 12/31/20212,330,000 shares $7.76 million -22.9%28.1%0.1 $3.33 12/15/20213,020,000 shares $8.67 million +41.1%35.7%0.2 $2.87 11/30/20212,140,000 shares $6.12 million +459.6%55.9%0.2 $2.86 11/15/2021382,400 shares $833,632.00 +359.6%8.9%0.1 $2.18 10/29/202183,200 shares $144,768.00 -22.2%2.6%0 $1.74 10/15/2021106,900 shares $175,316.00 +20.0%1.8%1.2 $1.64 9/30/202189,100 shares $178,200.00 -22.9%1.5%1.6 $2.00 9/15/2021115,600 shares $239,292.00 -20.8%1.9%2.1 $2.07 8/31/2021145,900 shares $328,275.00 -16.1%2.4%1.8 $2.25 8/13/2021173,900 shares $525,178.00 -9.1%2.8%1.7 $3.02 7/30/2021191,200 shares $581,248.00 +19.3%3.1%0.9 $3.04 7/15/2021160,300 shares $488,915.00 +18.3%2.6%0.8 $3.05 6/30/2021135,500 shares $424,115.00 +21.1%2.2%0.7 $3.13Crypto Genius: 12,000% in 12 months? [Here’s how] (Ad)We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.If I’m right about this (like I was before) a modest $900 investment… 6/15/2021111,900 shares $349,128.00 +105.0%1.8%0.5 $3.12 5/28/202154,600 shares $165,438.00 -1.1%0.9%0.3 $3.03 5/14/202155,200 shares $162,840.00 -18.9%0.9%0.3 $2.95 4/30/202168,100 shares $224,730.00 +6.2%1.1%1.4 $3.30 4/15/202164,100 shares $201,915.00 -19.0%1.0%0.8 $3.15 3/31/202179,100 shares $288,715.00 +4.2%1.3%0.9 $3.65 3/15/202175,900 shares $256,542.00 +20.5%1.2%0.5 $3.38 2/26/202163,000 shares $218,610.00 -9.1%1.0%0.4 $3.47 2/12/202169,300 shares $293,832.00 +234.8%1.1%0.4 $4.24 1/29/202120,700 shares $70,173.00 +269.6%0.3%0.1 $3.39 1/15/20215,600 shares $24,136.00 No ChangeN/A0 $4.31 PTPI Short Interest - Frequently Asked Questions What is Petros Pharmaceuticals' current short interest? Short interest is the volume of Petros Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 745,300 shares of PTPI short. 7.50% of Petros Pharmaceuticals' shares are currently sold short. Learn More on Petros Pharmaceuticals' current short interest. Which institutional investors are shorting Petros Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Petros Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Petros Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.50% of Petros Pharmaceuticals' floating shares are currently sold short. Is Petros Pharmaceuticals' short interest increasing or decreasing? Petros Pharmaceuticals saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 745,300 shares, an increase of 113.1% from the previous total of 349,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Petros Pharmaceuticals' short interest compare to its competitors? 7.50% of Petros Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Petros Pharmaceuticals: Conduit Pharmaceuticals Inc. (105.83%), Genprex, Inc. (4.03%), Lipella Pharmaceuticals Inc. (2.94%), Upexi, Inc. (3.82%), Tharimmune, Inc. (1.59%), Psyence Biomedical Ltd. (28.27%), Matinas Biopharma Holdings, Inc. (0.66%), Lixte Biotechnology Holdings, Inc. (2.87%), Scinai Immunotherapeutics Ltd. (1.11%), CERo Therapeutics Holdings, Inc. (34.57%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Petros Pharmaceuticals stock? Short selling PTPI is an investing strategy that aims to generate trading profit from Petros Pharmaceuticals as its price is falling. PTPI shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Petros Pharmaceuticals? A short squeeze for Petros Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PTPI, which in turn drives the price of the stock up even further. How often is Petros Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTPI, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies Conduit Pharmaceuticals Short Squeeze Genprex Short Squeeze Lipella Pharmaceuticals Short Squeeze Upexi Short Squeeze Tharimmune Short Squeeze Psyence Biomedical Short Squeeze Matinas Biopharma Short Squeeze Lixte Biotechnology Short Squeeze Scinai Immunotherapeutics Short Squeeze CERo Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PTPI) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petros Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Petros Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.